The online process could hurt pharma exports, Pharmexcil said, even as drugmakers face slower approvals and increased scrutiny in foreign markets.
The online process could hurt pharma exports, Pharmexcil said, even as drugmakers face slower approvals and increased scrutiny in foreign markets.